Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
作者信息
Newall A T, Jit M, Hutubessy R
机构信息
School of Public Health and Community Medicine, Faculty of Medicine, UNSW Australia, Sydney, NSW, 2052, Australia,
出版信息
Pharmacoeconomics. 2014 Dec;32(12):1247. doi: 10.1007/s40273-014-0232-0.
PMID:25374292
Abstract
摘要
Zotero 插件